TITLE

HIV never sleeps, loves a good, stiff drink

PUB. DATE
May 1993
SOURCE
Advocate;5/4/93, Issue 628, p14
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports on the development of HIV infection. Development of AIDS symptoms; Risks for HIV infection.
ACCESSION #
9590396

Tags: HIV infections;  VIRUS diseases

 

Related Articles

  • Longer AIDS-Free Survival.  // AIDS Patient Care & STDs;Sep98, Vol. 12 Issue 9, p667 

    States that children who were perinatally infected with HIV-1 exhibited a longer AIDS-free survival. Percentage of 190 children infected between 1986 and 1997 which produced these findings; Decline in AIDS progression; What these results suggest.

  • Influence of Human Immunodeficiency Virus Type 1 Infection on Acute Hepatitis A Virus Infection. Ida, Setsuko; Tachikawa, Natsuo; Nakajima, Aya; Daikoku, Manabu; Yano, Michitami; Kikuchi, Yoshimi; Yasuoka, Akira; Kimura, Satoshi; Oka, Shinichi // Clinical Infectious Diseases;2/1/2002, Vol. 34 Issue 3, p379 

    To assess the possible influence of human immunodeficiency virus type 1 (HIV-1) infection on the clinical course of acute hepatitis A virus (HAV) infection, 15 HIV-1--infected homosexual men and 15 non--HIV-infected age-matched subjects were compared. HAV load was higher in HIV-1--infected...

  • Advances in the prevention and treatment of paediatric HIV infection in the United Kingdom. Sharland, M.; Gibbs, D.M.; Tudor-Williams, G. // Sexually Transmitted Infections;Feb2003, Vol. 79 Issue 1, p53 

    Summarizes the advances in the prevention and treatment of pediatric HIV infection in Great Britain. Mother to child transmission of HIV infection; Managing HIV infected children; Clinical management of children with HIV.

  • In vitro models of mucosal HIV transmission. Shattock, Robin J; Griffin, George E; Gorodeski, George I // Nature Medicine;Jun2000, Vol. 6 Issue 6, p607 

    Comments on an article by Kelly Collins et al on vitro models of mucosal HIV transmission published in the April 2000 issue of 'Nature Medicine' periodical. Absence of data which showed that controls were used to eliminate the possibility that inoculating virus has access to the tissue;...

  • Anticipating and blocking HIV-1 escape by second generation antiviral shRNAs. Schopman, Nick C. T.; ter Brake, Olivier; Berkhout, Ben // Retrovirology;2010, Vol. 7, p52 

    Background: RNA interference (RNAi) is an evolutionary conserved gene silencing mechanism that mediates the sequence-specific breakdown of target mRNAs. RNAi can be used to inhibit HIV-1 replication by targeting the viral RNA genome. However, the error-prone replication machinery of HIV-1 can...

  • Virological, Immunological, and Clinical Impact of Switching from Protease Inhibitors to Nevirapine or to Efavirenz in Patients with Human Immunodeficiency Virus Infection and Long-Lasting Viral Suppression. Negredo, Eugenia; Cruz, Luis; Paredes, Roger; Ruiz, Lidia; Fumaz, Carmina R.; Bonjoch, Anna; Gel, Silvia; Tuldra, Albert; Balague, Montserrat; Johnston, Susan; Arno, Albert; Jou, Antoni; Tural, Cristina; Sirera, Guillem; Romeu, Joan; Clotet, Bonaventura // Clinical Infectious Diseases;2/15/2002, Vol. 34 Issue 4, p504 

    Seventy-seven subjects infected with human immunodeficiency virus were randomized to switch fromprotease inhibitor (PI) therapy to nevirapine therapy (group A; n=26) or to efavirenz therapy (group B; n=25) or to continue PI therapy (group C; n=26). At month 12, viral suppression had been...

  • Influence of Coinfection with Hepatitis C Virus on Morbidity and Mortality Due to Human Immunodeficiency Virus Infection in the Era of Highly Active Antiretroviral Therapy. Tedaldi, Ellen M.; Baker, Rose K.; Moorman, Anne C.; Alzola, Carlos F.; Furhrer, Jack; McCabe, Robert E.; Wood, Kathleen C.; Holmberg, Scott D. // Clinical Infectious Diseases;2/1/2003, Vol. 36 Issue 3, p363 

    To ascertain the impact of hepatitis C virus (HCV) infection on human immunodeficiency virus (HIV) disease progression and associated death in the era of highly active antiretroviral therapy (HAART), we examined mortality rates, the presence of other diseases, and antiretroviral use in an...

  • First Things First: Balancing Hepatitis C and Human Immunodeficiency Virus. Graham, Camilla S.; Koziel, Margaret James // Clinical Infectious Diseases;2/1/2003, Vol. 36 Issue 3, p368 

    Editorial. Comments on a study by Tedaldi and colleagues, about the coinfection of HIV and hepatitis C virus. Influence of coinfection on morbidity and mortality; Balancing the risks and benefits of treating each of these viral infections; Impact of the availability of highly active...

  • Effect of Chemokine Receptor Mutations on Heterosexual Human. Lockett, Sarah F.; Alonso, Alicia; Wyld, Rona; Martin, Maureen P.; Robertson, J. Roy; Gore, Sheila M.; Leen, Clifford L.S.; Brettle, Ray P.; Yirrell, David L.; Carrington, Mary; Brown, Andrew J. Leigh // Journal of Infectious Diseases;9/1/99, Vol. 180 Issue 3, p614 

    Examines the effect of chemokine receptor mutations on heterosexual HIV transmission. Allelle frequency of 64I heterozygotes in women involved in the study; Risk factor for HIV infection of women after heterosexual contact; Genetic factors that affect the rate of progression to disease in...

Share

Read the Article

Courtesy of your local library

Public Libraries Near You (See All)
Looking for a Different Library?

Other Topics